Since GBM was one of the first solid tumors in which CSCs were identified [3, 4] and based on our previous work implicating NF-κB signaling in breast CSCs [39], we next asked if these findings could be explained by a role for NF-κB signaling in the growth of GSCs. This evidence concerns the gene NFKB1 and glioblastoma.